Tyra Biosciences, Inc.
- Last sale
- Nov 9, 2026 · +5.37%
- Market cap
- $1.54B
- 69.08M shares
- Filings
- 428
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−15.9% FY25 yoy
- $1.54B
- —
- —
- 2.2×
- -6.19%
- —
FY2025 figures · derived
Price
Nov 9, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $102,928,000 | reported | |
| FY 2024 | 2024-12-31 | $80,077,000 | reported | |
| FY 2023 | 2023-12-31 | $62,518,000 | reported | |
| FY 2022 | 2022-12-31 | $43,008,000 | reported | |
| FY 2021 | 2021-12-31 | $20,636,000 | reported | |
| FY 2020 | 2020-12-31 | $7,203,000 | reported |
Pharmaceutical preparations
Tyra Biosciences, Inc. is the 115th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
GENBGenerate Biomedicines, Inc.———$1.6BANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6BNBTXNanobiotix S.A.———$1.6BETONEton Pharmaceuticals, Inc.$80.0M104.9%5.8%$1.6BRAREUltragenyx Pharmaceutical Inc.$673.0M20.2%85.4%$1.6B
TYRATyra Biosciences, Inc. (this company)———$1.5B
SNDXSyndax Pharmaceuticals Inc$172.4M627.8%165.6%$1.5BRAPPRapport Therapeutics, Inc.———$1.5BPCRXPacira BioSciences, Inc.$726.4M3.6%1.0%$1.5BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Tyra Biosciences, Inc. · CIK 1863127 · Engraved from SEC EDGAR